Breaking News Instant updates and real-time market news.

H

Hyatt

$78.52 /

-0.15 (-0.19%)

16:32
02/17/21
02/17
16:32
02/17/21
16:32

Hyatt reports Q4 comparable systemwide RevPAR down 68.9%

  • 18

    Feb

  • 01

    Mar

H Hyatt
$78.52 /

-0.15 (-0.19%)

02/12/21 Berenberg
Hyatt downgraded to Sell from Hold at Berenberg
01/05/21 Gordon Haskett
Hyatt price target raised to $71 from $61 at Gordon Haskett
12/22/20
Fly Intel: Top five analyst downgrades
12/22/20 Longbow
Hyatt downgraded to Neutral on valuation at Longbow

TODAY'S FREE FLY STORIES

General news
Asian Market Update: » 01:55
03/05/21
03/05
01:55
03/05/21
01:55

Asian Market Update:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
U.S. trade preview » 01:55
03/05/21
03/05
01:55
03/05/21
01:55

U.S. trade preview: the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
U.S. nonfarm payroll preview » 01:55
03/05/21
03/05
01:55
03/05/21
01:55

U.S. nonfarm payroll…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
BoJ's Kuroda sees no need to widen yield band. » 01:30
03/05/21
03/05
01:30
03/05/21
01:30

BoJ's Kuroda sees no…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
Paycom upgraded to Buy from Hold at Jefferies » 21:28
03/04/21
03/04
21:28
03/04/21
21:28
PAYC

Paycom

$348.26 /

-14.54 (-4.01%)

Jefferies analyst Samad…

Jefferies analyst Samad Samana upgraded Paycom Software to Buy from Hold with a $470 price target. The analyst cites valuation for the upgrade following the recent selloff. The stock is off 25% from all-time highs and 23% year-to-date, with the valuation now below the pre-pandemic peak, Samana tells investors in a research note. Fundamentally, Paycom is well positioned to return to greater than 20% growth in 2021 and sustain acceleration into 2022 on "strong" new bookings, says Samana. Further, employment tailwinds "would be an extra boost," says the analyst.

ShowHide Related Items >><<
PAYC Paycom
$348.26 /

-14.54 (-4.01%)

PAYC Paycom
$348.26 /

-14.54 (-4.01%)

02/11/21 KeyBanc
Paycom price target raised to $500 from $475 at KeyBanc
02/11/21 Cowen
Paycom price target raised to $475 from $437 at Cowen
02/11/21 RBC Capital
Paycom price target raised to $470 from $430 at RBC Capital
01/11/21 Barclays
Paycom price target raised to $460 from $378 at Barclays
PAYC Paycom
$348.26 /

-14.54 (-4.01%)

PAYC Paycom
$348.26 /

-14.54 (-4.01%)

Recommendations
NextCure price target lowered to $26 from $32 at Piper Sandler » 20:39
03/04/21
03/04
20:39
03/04/21
20:39
NXTC

NextCure

$11.38 /

-0.22 (-1.90%)

Piper Sandler analyst…

Piper Sandler analyst Edward Tenthoff lowered the firm's price target on NextCure to $26 from $32 and keeps an Overweight rating on the shares after its FY20 results. The analyst notes that his updated price target reflect the company's pipeline value realignment and a reduction in projected enterprise value of $527M, down from $663M, though its NC318 S15+ and NC410 data readouts remain on track for Q4 of this year.

ShowHide Related Items >><<
NXTC NextCure
$11.38 /

-0.22 (-1.90%)

NXTC NextCure
$11.38 /

-0.22 (-1.90%)

01/15/21 BofA
NextCure downgraded to Underperform on low conviction in NC318 at BofA
01/15/21 BofA
NextCure downgraded to Underperform from Neutral at BofA
01/05/21 Benchmark
GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021
07/16/20 Benchmark
Benchmark sees NextCure selloff as overdone, upgrades to Buy
NXTC NextCure
$11.38 /

-0.22 (-1.90%)

Earnings
NextCure reports FY20 EPS ($1.33), consensus ($1.34) » 20:35
03/04/21
03/04
20:35
03/04/21
20:35
NXTC

NextCure

$11.38 /

-0.22 (-1.90%)

Cash, cash equivalents,…

Cash, cash equivalents, and marketable securities, excluding restricted cash as of December 31, 2020, were $283.4 million as compared with $334.6 million as of December 31, 2019. The company states: "Based on its current research and development plans, NextCure expects its existing cash, cash equivalents and marketable securities will enable it to fund operating expenses and capital expenditure requirements into the second half of 2023."

ShowHide Related Items >><<
NXTC NextCure
$11.38 /

-0.22 (-1.90%)

NXTC NextCure
$11.38 /

-0.22 (-1.90%)

01/15/21 BofA
NextCure downgraded to Underperform on low conviction in NC318 at BofA
01/15/21 BofA
NextCure downgraded to Underperform from Neutral at BofA
01/05/21 Benchmark
GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021
07/16/20 Benchmark
Benchmark sees NextCure selloff as overdone, upgrades to Buy
NXTC NextCure
$11.38 /

-0.22 (-1.90%)

Syndicate
Nurix Therapeutics 4.5M share Secondary priced at $31.00 » 20:03
03/04/21
03/04
20:03
03/04/21
20:03
NRIX

Nurix Therapeutics

$32.30 /

-0.45 (-1.37%)

The deal size was…

The deal size was increased to 4.5M shares from 4.0M and priced below the last closing price of $32.49. JPMorgan, Piper Sandler and Stifel are acting as joint book running managers for the offering.

ShowHide Related Items >><<
NRIX Nurix Therapeutics
$32.30 /

-0.45 (-1.37%)

NRIX Nurix Therapeutics
$32.30 /

-0.45 (-1.37%)

02/17/21 Piper Sandler
Nurix Therapeutics price target raised to $60 from $40 at Piper Sandler
02/16/21 Piper Sandler
Nurix Therapeutics price target raised to $60 from $40 at Piper Sandler
01/29/21 JPMorgan
Nurix Therapeutics price target raised to $56 from $34 at JPMorgan
11/24/20 Morgan Stanley
Kymera Therapeutics price target raised to $45 from $27 at Morgan Stanley
NRIX Nurix Therapeutics
$32.30 /

-0.45 (-1.37%)

  • 05
    Mar
  • 24
    Jul
Hot Stocks
ShotSpotter CFO buys 7.5K shares of common stock » 19:52
03/04/21
03/04
19:52
03/04/21
19:52
SSTI

ShotSpotter

$35.86 /

-0.76 (-2.08%)

In a regulatory filing,…

In a regulatory filing, ShotSpotter disclosed that its CFO Alan Stewart bought 7.5K shares of common stock on March 3rd in a total transaction size of $285K.

ShowHide Related Items >><<
SSTI ShotSpotter
$35.86 /

-0.76 (-2.08%)

SSTI ShotSpotter
$35.86 /

-0.76 (-2.08%)

02/26/21 Northland
ShotSpotter price target raised to $49 from $40 at Northland
02/26/21 Roth Capital
ShotSpotter price target raised to $53 from $41 at Roth Capital
02/03/21 Craig-Hallum
ShotSpotter price target raised to $45 from $29 at Craig-Hallum
11/10/20 JMP Securities
ShotSpotter downgraded to Market Perform from Outperform at JMP Securities
SSTI ShotSpotter
$35.86 /

-0.76 (-2.08%)

SSTI ShotSpotter
$35.86 /

-0.76 (-2.08%)

Syndicate
Sun Communities 7M share Secondary priced at $140.00 » 19:11
03/04/21
03/04
19:11
03/04/21
19:11
SUI

Sun Communities

$141.75 /

-8.17 (-5.45%)

The deal priced below the…

The deal priced below the last closing price of $141.80. Citi, BofA, BMO Capital, JPMorgan and RBC Capital are acting as joint book running managers for the offering.

ShowHide Related Items >><<
SUI Sun Communities
$141.75 /

-8.17 (-5.45%)

SUI Sun Communities
$141.75 /

-8.17 (-5.45%)

12/15/20 Citi
Sun Communities upgraded to Buy from Neutral at Citi
10/01/20 BMO Capital
Sun Communities price target raised to $165 from $160 at BMO Capital
10/01/20 Berenberg
Sun Communities initiated with a Buy at Berenberg
03/30/20 Evercore ISI
Sun Communities upgraded to Outperform from In Line at Evercore ISI
SUI Sun Communities
$141.75 /

-8.17 (-5.45%)

  • 05
    Mar
  • 01
    Oct
  • 29
    Apr
On The Fly
Fly Intel: After-Hours Movers » 19:09
03/04/21
03/04
19:09
03/04/21
19:09
PLYA

Playa Hotels & Resorts

$6.90 /

-0.105 (-1.50%)

, MANU

Manchester United

$18.72 /

-0.84 (-4.29%)

, GPS

Gap

$25.43 /

-0.31 (-1.20%)

, NX

Quanex

$24.56 /

-0.26 (-1.05%)

, COO

Cooper Companies

$371.84 /

-9.125 (-2.40%)

, ATEC

Alphatec

$15.86 /

-0.69 (-4.17%)

, SWBI

Smith & Wesson Brands

$15.79 /

-0.54 (-3.31%)

, IMAX

Imax

$20.78 /

-0.98 (-4.50%)

, JAMF

Jamf Holding

$36.45 /

-1.33 (-3.52%)

, WTRH

Waitr Holdings

$2.99 /

-0.19 (-5.97%)

, OCUL

Ocular Therapeutix

$17.29 /

-0.31 (-1.76%)

, WDC

Western Digital

$63.48 /

-6.3 (-9.03%)

, EVFM

Evofem

$3.27 /

-0.325 (-9.05%)

, MDLA

Medallia

$37.82 /

-2.01 (-5.05%)

, DMTK

DermTech

$52.64 /

-11.36 (-17.75%)

, OPEN

Opendoor Technologies

$24.40 /

-4.46 (-15.45%)

, SDC

SmileDirectClub

$10.63 /

-0.28 (-2.57%)

, GWRE

Guidewire

$106.80 /

-2.79 (-2.55%)

, COST

Costco

$319.35 /

-4.53 (-1.40%)

, AVGO

Broadcom

$443.23 /

-19.235 (-4.16%)

, WORK

Slack Technologies

$39.97 /

-0.26 (-0.65%)

Check out this evening's…

ShowHide Related Items >><<
WTRH Waitr Holdings
$2.99 /

-0.19 (-5.97%)

WORK Slack Technologies
$39.97 /

-0.26 (-0.65%)

WDC Western Digital
$63.48 /

-6.3 (-9.03%)

SWBI Smith & Wesson Brands
$15.79 /

-0.54 (-3.31%)

SDC SmileDirectClub
$10.63 /

-0.28 (-2.57%)

PLYA Playa Hotels & Resorts
$6.90 /

-0.105 (-1.50%)

OPEN Opendoor Technologies
$24.40 /

-4.46 (-15.45%)

OCUL Ocular Therapeutix
$17.29 /

-0.31 (-1.76%)

NX Quanex
$24.56 /

-0.26 (-1.05%)

MDLA Medallia
$37.82 /

-2.01 (-5.05%)

MANU Manchester United
$18.72 /

-0.84 (-4.29%)

JAMF Jamf Holding
$36.45 /

-1.33 (-3.52%)

IMAX Imax
$20.78 /

-0.98 (-4.50%)

GWRE Guidewire
$106.80 /

-2.79 (-2.55%)

GPS Gap
$25.43 /

-0.31 (-1.20%)

EVFM Evofem
$3.27 /

-0.325 (-9.05%)

DMTK DermTech
$52.64 /

-11.36 (-17.75%)

COST Costco
$319.35 /

-4.53 (-1.40%)

COO Cooper Companies
$371.84 /

-9.125 (-2.40%)

AVGO Broadcom
$443.23 /

-19.235 (-4.16%)

ATEC Alphatec
$15.86 /

-0.69 (-4.17%)

PLYA Playa Hotels & Resorts
$6.90 /

-0.105 (-1.50%)

01/11/21 Macquarie
Playa Hotels & Resorts price target raised to $8 from $7 at Macquarie
12/15/20 Citi
Playa Hotels & Resorts upgraded to Neutral from Sell at Citi
07/02/20 Citi
Playa Hotels & Resorts price target raised to $3 from $1 at Citi
04/29/20 Truist
Playa Hotels & Resorts downgraded to Hold from Buy at SunTrust
MANU Manchester United
$18.72 /

-0.84 (-4.29%)

GPS Gap
$25.43 /

-0.31 (-1.20%)

02/16/21 Jefferies
Gap assumed with a Hold at Jefferies
01/21/21 Deutsche Bank
Gap price target raised to $26 from $25 at Deutsche Bank
01/15/21 B. Riley Securities
Gap price target lowered to $22 from $31 at B. Riley Securities
11/25/20
Fly Intel: Top five analyst downgrades
NX Quanex
$24.56 /

-0.26 (-1.05%)

09/04/20 CJS Securities
Quanex upgraded to Outperform from Market Perform at CJS Securities
04/02/20 Benchmark
Benchmark starts Quanex at Buy with stock back at 2009 levels
04/02/20 Benchmark
Quanex initiated with a Buy at Benchmark
03/10/20 Sidoti
Quanex upgraded to Buy from Neutral at Sidoti
COO Cooper Companies
$371.84 /

-9.125 (-2.40%)

02/11/21 Piper Sandler
Cooper Companies price target raised to $435 from $370 at Piper Sandler
01/25/21 Wells Fargo
Cooper Companies price target raised to $445 from $415 at Wells Fargo
12/04/20 Citi
Cooper Companies price target raised to $355 from $330 at Citi
12/04/20 KeyBanc
Cooper Companies price target raised to $367 from $349 at KeyBanc
ATEC Alphatec
$15.86 /

-0.69 (-4.17%)

01/29/21 Piper Sandler
Alphatec price target raised to $17 from $12 at Piper Sandler
01/12/21 Piper Sandler
Piper remains buyer of Alphatec despite Covid pressures
12/21/20 H.C. Wainwright
Alphatec price target raised to $16 from $12 at H.C. Wainwright
12/18/20 Lake Street
Alphatec price target raised to $20 from $15 at Lake Street
SWBI Smith & Wesson Brands
$15.79 /

-0.54 (-3.31%)

03/04/21 B. Riley Securities
B. Riley starts American Outdoor Brands with Buy, $32 price target
12/04/20 Lake Street
Lake Street ups Smith & Wesson Brands price target to $28 after earnings
10/05/20 B. Riley Securities
Firearm demand has seen meaningful uptick, says B. Riley Securities
09/24/20
Fly Intel: Top five analyst initiations
IMAX Imax
$20.78 /

-0.98 (-4.50%)

03/01/21 Wedbush
Imax price target raised to $22 from $14 at Wedbush
02/16/21 B. Riley Securities
IMAX format positioned to gain post-pandemic share, says B. Riley Securities
02/16/21 Macquarie
Imax remains best way to play theatrical space, says Macquarie
02/15/21 Benchmark
Benchmark boosts Imax target to $22, says movie goers will return
JAMF Jamf Holding
$36.45 /

-1.33 (-3.52%)

01/28/21 Piper Sandler
Jamf Holding remains a top idea for 2021 at Piper Sandler
01/05/21 Canaccord
Jamf Holding metrics 'bode well' for strong Q4, says Canaccord
09/02/20 Canaccord
Jamf Holding upside likely in Q3, says Canaccord
08/17/20
Fly Intel: Top five analyst initiations
WTRH Waitr Holdings
$2.99 /

-0.19 (-5.97%)

11/10/20 B. Riley Securities
Waitr Holdings price target lowered to $7 from $8 at B. Riley Securities
07/22/20 B. Riley Securities
B. Riley FBR starts Waitr at Buy, calls attractive takeout candidate
07/22/20 B. Riley Securities
Waitr Holdings initiated with a Buy at B. Riley FBR
07/09/20 Deutsche Bank
Waitr Holdings downgraded to Hold on valuation at Deutsche Bank
OCUL Ocular Therapeutix
$17.29 /

-0.31 (-1.76%)

02/12/21 Piper Sandler
Ocular Therapeutix to update on OTX-TKI's Phase I wAMD, says Piper Sandler
12/30/20 JMP Securities
Ocular Therapeutix price target raised to $30 from $20 at JMP Securities
12/28/20
Fly Intel: Top five analyst calls
12/28/20 H.C. Wainwright
Ocular Therapeutix downgraded to Neutral from Buy at H.C. Wainwright
WDC Western Digital
$63.48 /

-6.3 (-9.03%)

03/04/21 Goldman Sachs
Western Digital upgraded to Buy from Neutral at Goldman Sachs
03/01/21 Barclays
Western Digital price target raised to $75 from $53 at Barclays
02/25/21 Mizuho
Western Digital price target raised to $80 from $65 at Mizuho
02/24/21 Benchmark
Benchmark says Biden order bodes well for Nova Measuring, other semi suppliers
EVFM Evofem
$3.27 /

-0.325 (-9.05%)

10/01/20 Stifel
Evofem initiated with a Buy at Stifel
08/20/20 Morgan Stanley
Evofem initiated with an Equal Weight at Morgan Stanley
08/20/20 Morgan Stanley
Evofem initiated with an Equal Weight at Morgan Stanley
08/10/20 Oppenheimer
Evofem price target raised to $25 from $18 at Oppenheimer
MDLA Medallia
$37.82 /

-2.01 (-5.05%)

03/04/21 Citi
Citi adds Medallia to 'Value Creators' list, removes Dropbox
02/23/21 Citi
Medallia upgraded to Buy from Neutral at Citi
01/19/21 BTIG
Medallia price target raised to $49 from $37 at BTIG
01/19/21 BofA
Medallia initiated with a Buy at BofA
DMTK DermTech
$52.64 /

-11.36 (-17.75%)

02/11/21 Lake Street
DermTech price target raised to $79 from $52 at Lake Street
01/21/21 Oppenheimer
Oppenheimer starts DermTech with Outperform, $53 target
01/21/21 Oppenheimer
DermTech initiated with an Outperform at Oppenheimer
01/20/21 Craig-Hallum
DermTech price target raised to $49 from $23 at Craig-Hallum
OPEN Opendoor Technologies
$24.40 /

-4.46 (-15.45%)

03/01/21 Credit Suisse
Opendoor Technologies initiated with an Outperform at Credit Suisse
02/19/21
Fly Intel: Top five analyst initiations
02/19/21 KeyBanc
Opendoor Technologies initiated with an Overweight at KeyBanc
01/06/21 Wedbush
Wedbush bullish on Opendoor Technologies, initiates with an Outperform
SDC SmileDirectClub
$10.63 /

-0.28 (-2.57%)

12/08/20 Wolfe Research
SmileDirectClub upgraded to Outperform from Peer Perform at Wolfe Research
11/24/20 JPMorgan
JPMorgan reiterates Overweight on SmileDirectClub after management meetings
09/17/20 Stifel
SmileDirectClub price target raised to $14 from $11 at Stifel
09/09/20 Wolfe Research
Wolfe Research upgrades SmileDirectClub to Peer Perform as shifts pay off
GWRE Guidewire
$106.80 /

-2.79 (-2.55%)

01/13/21 Goldman Sachs
Sapiens initiated with a Neutral at Goldman Sachs
10/14/20 DA Davidson
Guidewire model reset is 'right move', says DA Davidson
10/14/20 Needham
Guidewire price target lowered to $130 from $145 at Needham
09/08/20 Barclays
Duck Creek Technologies initiated with an Equal Weight at Barclays
COST Costco
$319.35 /

-4.53 (-1.40%)

02/03/21 Baird
Costco January core comps re-accelerated, says Baird
02/02/21 Cleveland Research
Costco U.S. sales slightly improved in January, says Cleveland Research
01/07/21 Deutsche Bank
Costco price target raised to $347 from $344 at Deutsche Bank
01/06/21 Baird
Costco saw some deceleration in December core comp sales, says Baird
AVGO Broadcom
$443.23 /

-19.235 (-4.16%)

03/02/21 Credit Suisse
Broadcom price target raised to $580 from $480 at Credit Suisse
03/01/21 JPMorgan
Broadcom won new new wireless charging chipset in iPhone 13, says JPMorgan
02/26/21 Oppenheimer
Broadcom price target raised to $575 from $500 at Oppenheimer
02/26/21 Oppenheimer
Broadcom price target raised to $575 from $500 at Oppenheimer
WORK Slack Technologies
$39.97 /

-0.26 (-0.65%)

12/09/20 Morgan Stanley
Salesforce $50B revenue target unlikely a source of upside, says Morgan Stanley
12/09/20 Canaccord
Salesforce valuation compelling especially on pullback, says Canaccord
12/09/20 Morgan Stanley
Slack Technologies upgraded to Equal Weight from Underweight at Morgan Stanley
12/03/20 Wedbush
Slack Technologies upgraded to Neutral from Underperform at Wedbush
WTRH Waitr Holdings
$2.99 /

-0.19 (-5.97%)

WORK Slack Technologies
$39.97 /

-0.26 (-0.65%)

WDC Western Digital
$63.48 /

-6.3 (-9.03%)

SWBI Smith & Wesson Brands
$15.79 /

-0.54 (-3.31%)

SDC SmileDirectClub
$10.63 /

-0.28 (-2.57%)

PLYA Playa Hotels & Resorts
$6.90 /

-0.105 (-1.50%)

OPEN Opendoor Technologies
$24.40 /

-4.46 (-15.45%)

OCUL Ocular Therapeutix
$17.29 /

-0.31 (-1.76%)

NX Quanex
$24.56 /

-0.26 (-1.05%)

MDLA Medallia
$37.82 /

-2.01 (-5.05%)

MANU Manchester United
$18.72 /

-0.84 (-4.29%)

JAMF Jamf Holding
$36.45 /

-1.33 (-3.52%)

IMAX Imax
$20.78 /

-0.98 (-4.50%)

GWRE Guidewire
$106.80 /

-2.79 (-2.55%)

GPS Gap
$25.43 /

-0.31 (-1.20%)

EVFM Evofem
$3.27 /

-0.325 (-9.05%)

DMTK DermTech
$52.64 /

-11.36 (-17.75%)

COST Costco
$319.35 /

-4.53 (-1.40%)

COO Cooper Companies
$371.84 /

-9.125 (-2.40%)

AVGO Broadcom
$443.23 /

-19.235 (-4.16%)

ATEC Alphatec
$15.86 /

-0.69 (-4.17%)

  • 05
    Feb
  • 07
    Jan
  • 07
    Jan
  • 16
    Dec
  • 24
    Nov
  • 19
    Nov
  • 19
    Nov
  • 19
    Nov
  • 14
    Oct
  • 14
    Oct
  • 22
    Jul
  • 03
    Jun
  • 20
    May
WORK Slack Technologies
$39.97 /

-0.26 (-0.65%)

WDC Western Digital
$63.48 /

-6.3 (-9.03%)

SWBI Smith & Wesson Brands
$15.79 /

-0.54 (-3.31%)

SDC SmileDirectClub
$10.63 /

-0.28 (-2.57%)

OPEN Opendoor Technologies
$24.40 /

-4.46 (-15.45%)

IMAX Imax
$20.78 /

-0.98 (-4.50%)

GPS Gap
$25.43 /

-0.31 (-1.20%)

COST Costco
$319.35 /

-4.53 (-1.40%)

WTRH Waitr Holdings
$2.99 /

-0.19 (-5.97%)

WORK Slack Technologies
$39.97 /

-0.26 (-0.65%)

WDC Western Digital
$63.48 /

-6.3 (-9.03%)

SWBI Smith & Wesson Brands
$15.79 /

-0.54 (-3.31%)

SDC SmileDirectClub
$10.63 /

-0.28 (-2.57%)

PLYA Playa Hotels & Resorts
$6.90 /

-0.105 (-1.50%)

OPEN Opendoor Technologies
$24.40 /

-4.46 (-15.45%)

OCUL Ocular Therapeutix
$17.29 /

-0.31 (-1.76%)

NX Quanex
$24.56 /

-0.26 (-1.05%)

IMAX Imax
$20.78 /

-0.98 (-4.50%)

GPS Gap
$25.43 /

-0.31 (-1.20%)

DMTK DermTech
$52.64 /

-11.36 (-17.75%)

COST Costco
$319.35 /

-4.53 (-1.40%)

AVGO Broadcom
$443.23 /

-19.235 (-4.16%)

ATEC Alphatec
$15.86 /

-0.69 (-4.17%)

WORK Slack Technologies
$39.97 /

-0.26 (-0.65%)

WDC Western Digital
$63.48 /

-6.3 (-9.03%)

SWBI Smith & Wesson Brands
$15.79 /

-0.54 (-3.31%)

SDC SmileDirectClub
$10.63 /

-0.28 (-2.57%)

OPEN Opendoor Technologies
$24.40 /

-4.46 (-15.45%)

IMAX Imax
$20.78 /

-0.98 (-4.50%)

GPS Gap
$25.43 /

-0.31 (-1.20%)

EVFM Evofem
$3.27 /

-0.325 (-9.05%)

DMTK DermTech
$52.64 /

-11.36 (-17.75%)

COST Costco
$319.35 /

-4.53 (-1.40%)

AVGO Broadcom
$443.23 /

-19.235 (-4.16%)

Upgrade
Michaels upgraded to Equal Weight from Underweight at Morgan Stanley » 19:04
03/04/21
03/04
19:04
03/04/21
19:04
MIK

Michaels

$21.91 /

-0.075 (-0.34%)

Morgan Stanley analyst…

Morgan Stanley analyst Simeon Gutman upgraded Michaels to Equal Weight from Underweight with a $22 price target.

ShowHide Related Items >><<
MIK Michaels
$21.91 /

-0.075 (-0.34%)

MIK Michaels
$21.91 /

-0.075 (-0.34%)

03/03/21 Wells Fargo
Michaels deal with Apollo Global 'a win for shareholders,' says Wells Fargo
01/20/21 Morgan Stanley
Morgan Stanley downgrades Michaels to Underweight, sees 'too much optimism'
01/20/21 Morgan Stanley
Michaels downgraded to Underweight from Equal Weight at Morgan Stanley
12/14/20 JPMorgan
Michaels downgraded to Neutral after recent rally at JPMorgan
MIK Michaels
$21.91 /

-0.075 (-0.34%)

MIK Michaels
$21.91 /

-0.075 (-0.34%)

MIK Michaels
$21.91 /

-0.075 (-0.34%)

MIK Michaels
$21.91 /

-0.075 (-0.34%)

Downgrade
Five Prime downgraded to Hold from Buy at Jefferies » 19:03
03/04/21
03/04
19:03
03/04/21
19:03
FPRX

Five Prime

$38.03 /

+16.81 (+79.22%)

Jefferies analyst Eun…

Jefferies analyst Eun Yang downgraded Five Prime to Hold from Buy with a $38 price target.

ShowHide Related Items >><<
FPRX Five Prime
$38.03 /

+16.81 (+79.22%)

FPRX Five Prime
$38.03 /

+16.81 (+79.22%)

03/04/21 Piper Sandler
Amgen deal for Five Prime 'a nice tuck-in,' says Piper Sandler
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
03/04/21 Wedbush
Five Prime downgraded to Neutral from Outperform at Wedbush
03/04/21 Wells Fargo
Five Prime downgraded to Equal Weight from Overweight at Wells Fargo
FPRX Five Prime
$38.03 /

+16.81 (+79.22%)

  • 13
    Nov
FPRX Five Prime
$38.03 /

+16.81 (+79.22%)

FPRX Five Prime
$38.03 /

+16.81 (+79.22%)

Hot Stocks
Square director sells 8.2K shares of common stock » 18:42
03/04/21
03/04
18:42
03/04/21
18:42
SQ

Square

$218.43 /

-15.71 (-6.71%)

In a regulatory filing,…

In a regulatory filing, Square disclosed that its director Mary Meeker sold 8.2K shares of common stock on March 2nd in a total transaction size of $2.07M, reducing her holding by 2%.

ShowHide Related Items >><<
SQ Square
$218.43 /

-15.71 (-6.71%)

SQ Square
$218.43 /

-15.71 (-6.71%)

03/04/21 BTIG
Square purchase of Tidal stake looks like 'NFT play,' says BTIG
03/03/21 MoffettNathanson
MoffettNathanson says Square gross profit can grow at over 35% CAGR through 2023
02/25/21
Fly Intel: Top five analyst upgrades
02/25/21 BMO Capital
Square price target raised to $237 from $229 at BMO Capital
SQ Square
$218.43 /

-15.71 (-6.71%)

SQ Square
$218.43 /

-15.71 (-6.71%)

SQ Square
$218.43 /

-15.71 (-6.71%)

SQ Square
$218.43 /

-15.71 (-6.71%)

Hot Stocks
TriMas' Parker sells over 21,000 common shares » 18:41
03/04/21
03/04
18:41
03/04/21
18:41
TRS

TriMas

$31.64 /

-0.5 (-1.56%)

In a regulatory filing,…

In a regulatory filing, TriMas director Herbert K. Parker disclosed the sale of 21,158 common shares of the company on March 2 at a price of $32.16 per share.

ShowHide Related Items >><<
TRS TriMas
$31.64 /

-0.5 (-1.56%)

TRS TriMas
$31.64 /

-0.5 (-1.56%)

04/02/20 William Blair
TriMas upgraded to Outperform from Market Perform at William Blair
TRS TriMas
$31.64 /

-0.5 (-1.56%)

Recommendations
Micron price target raised to $118 from $102 at Goldman Sachs » 18:39
03/04/21
03/04
18:39
03/04/21
18:39
MU

Micron

$84.35 /

-4.69 (-5.27%)

Goldman Sachs analyst…

Goldman Sachs analyst Toshiya Hari raised the firm's price target on Micron to $118 from $102 and keeps a Buy rating on the shares. Hari said that, based on his recent industry checks, he believes DRAM supply/demand dynamics have improved since his last earnings update. The analyst said that while feedback on enterprise demand remains muted or mixed, quantitative and anecdotal data points on essentially every other key end-market have continued to be robust or have strengthened. Hari also said that feedback on NAND supply/demand from industry discussions were "universally positive."

ShowHide Related Items >><<
MU Micron
$84.35 /

-4.69 (-5.27%)

MU Micron
$84.35 /

-4.69 (-5.27%)

03/03/21 Wells Fargo
Micron price target raised to $115 from $100 at Wells Fargo
03/03/21 Raymond James
Micron management expected to maintain bullish view on DRAM, says Raymond James
03/03/21 Lynx
Micron 'has become a crowded long,' says Lynx
03/03/21 Citi
Citi boosts Micron target to $116, still sees $150 stock longer term
MU Micron
$84.35 /

-4.69 (-5.27%)

MU Micron
$84.35 /

-4.69 (-5.27%)

MU Micron
$84.35 /

-4.69 (-5.27%)

MU Micron
$84.35 /

-4.69 (-5.27%)

Hot Stocks
PDC Energy's Crisafio sells 17,000 common shares » 18:33
03/04/21
03/04
18:33
03/04/21
18:33
PDCE

PDC Energy

$39.20 /

+3.74 (+10.55%)

In a regulatory filing,…

In a regulatory filing, PDC Energy director Anthony J. Crisafio disclosed the sale of 17,000 common shares of the company on March 3 at a price of $36.30 per share.

ShowHide Related Items >><<
PDCE PDC Energy
$39.20 /

+3.74 (+10.55%)

PDCE PDC Energy
$39.20 /

+3.74 (+10.55%)

02/25/21 JPMorgan
PDC Energy price target raised to $47 from $30 at JPMorgan
01/21/21 JPMorgan
PDC has roadmap to narrow discount to intrinsic value, says JPMorgan
01/21/21 Citi
PDC Energy price target raised to $30 from $21 at Citi
01/19/21 Cowen
PDC Energy price target raised to $33 from $27 at Cowen
PDCE PDC Energy
$39.20 /

+3.74 (+10.55%)

Hot Stocks
SPDR Gold Shares holdings fall from 1,082.38MT to 1,078.30MT » 18:30
03/04/21
03/04
18:30
03/04/21
18:30
GLD

SPDR Gold Shares

$159.04 /

-1.59 (-0.99%)

This is the lowest level…

This is the lowest level of holdings since May 7th, 2020.

ShowHide Related Items >><<
GLD SPDR Gold Shares
$159.04 /

-1.59 (-0.99%)

GLD SPDR Gold Shares
$159.04 /

-1.59 (-0.99%)

GLD SPDR Gold Shares
$159.04 /

-1.59 (-0.99%)

GLD SPDR Gold Shares
$159.04 /

-1.59 (-0.99%)

Periodicals
Wells Fargo to give all employees PTO for vaccine appointments, Reuters says » 18:26
03/04/21
03/04
18:26
03/04/21
18:26
WFC

Wells Fargo

$37.18 /

-0.51 (-1.35%)

Wells Fargo intends to…

Wells Fargo intends to give all employees up to eight hours of paid time off to accommodate coronavirus vaccine appointments, Reuters' Imani Moise reports, citing a memo. "While we understand that choosing to be vaccinated is a personal decision, we encourage you to consider getting the vaccine when it's available to you," head of human resources David Galloreese told all staff in a memo. Reference Link

ShowHide Related Items >><<
WFC Wells Fargo
$37.18 /

-0.51 (-1.35%)

WFC Wells Fargo
$37.18 /

-0.51 (-1.35%)

02/18/21
Fly Intel: Top five analyst upgrades
02/18/21 JPMorgan
Wells Fargo upgraded to Neutral with cap lift closer at JPMorgan
02/18/21 JPMorgan
Wells Fargo upgraded to Neutral from Underweight at JPMorgan
02/17/21 Goldman Sachs
Goldman says Fed approving Wells' risk overhaul plan would be 'important step'
WFC Wells Fargo
$37.18 /

-0.51 (-1.35%)

WFC Wells Fargo
$37.18 /

-0.51 (-1.35%)

WFC Wells Fargo
$37.18 /

-0.51 (-1.35%)

WFC Wells Fargo
$37.18 /

-0.51 (-1.35%)

Hot Stocks
Splunk CEO: We're growing our cloud business like no tomorrow » 18:25
03/04/21
03/04
18:25
03/04/21
18:25
SPLK

Splunk

$139.42 /

-3.89 (-2.71%)

In an interview on…

In an interview on CNBC's Mad Money, Doug Merritt said, "It's a tale of two businesses for Splunk." The company is growing cloud revenue very quickly he noted. Merritt said Splunk corrected in Q4 and changed a lot of its methodologies. "We're making long term investments for the health of our customers," he added.

ShowHide Related Items >><<
SPLK Splunk
$139.42 /

-3.89 (-2.71%)

SPLK Splunk
$139.42 /

-3.89 (-2.71%)

03/04/21 Goldman Sachs
Splunk price target lowered to $215 from $240 at Goldman Sachs
03/04/21 DA Davidson
Splunk price target lowered to $156 from $177 at DA Davidson
03/04/21 Barclays
Splunk price target lowered to $206 from $220 at Barclays
03/04/21 Baird
Splunk price target lowered to $200 from $215 at Baird
SPLK Splunk
$139.42 /

-3.89 (-2.71%)

SPLK Splunk
$139.42 /

-3.89 (-2.71%)

SPLK Splunk
$139.42 /

-3.89 (-2.71%)

SPLK Splunk
$139.42 /

-3.89 (-2.71%)

Upgrade
Western Digital upgraded to Buy from Neutral at Goldman Sachs » 18:10
03/04/21
03/04
18:10
03/04/21
18:10
WDC

Western Digital

$63.48 /

-6.3 (-9.03%)

Goldman Sachs analyst…

Goldman Sachs analyst Toshiya Hari upgraded Western Digital to Buy from Neutral with a price target of $85, up from $56. The analyst is citing his increased assumptions for DRAM and NAND memory pricing after the recent industry checks suggest improved demand environment and "continued" supply-side discipline. Hari adds that he is positive on Western Digital's improved NAND cost execution, and also believes that the company is positioned to regain market share that was lost in 2020.

ShowHide Related Items >><<
WDC Western Digital
$63.48 /

-6.3 (-9.03%)

WDC Western Digital
$63.48 /

-6.3 (-9.03%)

03/01/21 Barclays
Western Digital price target raised to $75 from $53 at Barclays
02/25/21 Mizuho
Western Digital price target raised to $80 from $65 at Mizuho
02/24/21 Benchmark
Benchmark says Biden order bodes well for Nova Measuring, other semi suppliers
02/24/21 Susquehanna
Western Digital price target raised to $100 from $85 at Susquehanna
WDC Western Digital
$63.48 /

-6.3 (-9.03%)

WDC Western Digital
$63.48 /

-6.3 (-9.03%)

WDC Western Digital
$63.48 /

-6.3 (-9.03%)

WDC Western Digital
$63.48 /

-6.3 (-9.03%)

Downgrade
Skyworks downgraded to Neutral from Buy at Goldman Sachs » 18:04
03/04/21
03/04
18:04
03/04/21
18:04
SWKS

Skyworks

$167.19 /

-8.03 (-4.58%)

Goldman Sachs analyst…

Goldman Sachs analyst Toshiya Hari downgraded Skyworks to Neutral from Buy with a $135 price target. Hari downgraded the stock given limited upside potential to his unchanged price target. The analyst added that while he remains constructive on the company's long-term competitive position in the growing radio frequency market, he anticipates that the stock will perform largely in line with his broader semiconductor and semiconductor capital equipment coverage universe through the balance of the year.

ShowHide Related Items >><<
SWKS Skyworks
$167.19 /

-8.03 (-4.58%)

SWKS Skyworks
$167.19 /

-8.03 (-4.58%)

02/16/21 Citi
Citi opens positive catalyst watch on Lam, negative watch on Skyworks
02/10/21 B. Riley Securities
B. Riley Securities sees interesting opportunities in Skyworks, Silicon Motion
02/03/21 BMO Capital
Qorvo price target raised to $190 from $135 at BMO Capital
02/02/21 Barclays
Cirrus Logic upside from Apple 'falls a bit short,' says Barclays
SWKS Skyworks
$167.19 /

-8.03 (-4.58%)

SWKS Skyworks
$167.19 /

-8.03 (-4.58%)

SWKS Skyworks
$167.19 /

-8.03 (-4.58%)

Hot Stocks
Oportun received Civil Investigative Demand from CFPB over collection practices » 17:44
03/04/21
03/04
17:44
03/04/21
17:44
OPRT

Oportun Financial

$18.42 /

+0.15 (+0.82%)

On March 3, Oportun, Inc.…

On March 3, Oportun, Inc. a subsidiary of Oportun Financial Corporation, received a Civil Investigative Demand from the Consumer Financial Protection Bureau. The stated purpose of the CID is to determine whether small-dollar lenders or associated persons, in connection with lending and debt-collection practices, have not been in compliance with certain federal consumer protection laws over which the CFPB has jurisdiction, the company disclosed in a regulatory filing. The information requests in the CID focus on Oportun's legal collection practices from 2019 to 2021 and hardship treatments offered during the COVID-19 pandemic. "The Company believes its practices have been in full compliance with CFPB guidance and that it has followed all published authority with respect to its practices, and the Company intends to cooperate with the CFPB. At this time, the Company is unable to predict the outcome of this CFPB investigation, including whether the investigation will result in any action or proceeding against the Company or in any changes to its practices," it said.

ShowHide Related Items >><<
OPRT Oportun Financial
$18.42 /

+0.15 (+0.82%)

01/19/21 JPMorgan
Oportun Financial price target raised to $19.50 from $17 at JPMorgan
12/17/20 BTIG
Oportun Financial price target raised to $23 from $19 at BTIG
12/10/20 Barclays
Oportun Financial price target raised to $23 from $19 at Barclays
09/20/20 BTIG
Oportun Financial pullback a buying opportunity, says BTIG
OPRT Oportun Financial
$18.42 /

+0.15 (+0.82%)

Hot Stocks
Genentech's Acterma approved by FDA for regulating pulmonary function in SSc-ILD » 17:44
03/04/21
03/04
17:44
03/04/21
17:44
RHHBY

Roche

$0.00 /

+ (+0.00%)

The company states:…

The company states: "Genentech, a member of the Roche Group,announced that the FDA approved Actemra, or tocilizumab, subcutaneous injection for slowing the rate of decline in pulmonary function in adult patients with systemic sclerosis-associated interstitial lung disease, a debilitating condition with limited treatment options. Actemra is the first biologic therapy approved by the FDA for the treatment of the disease. Systemic sclerosis, also known as scleroderma, is an often devastating autoimmune disease that worsens over time and has no cure. It occurs when the immune system malfunctions causing tissues of the skin and lungs to thicken and harden. SSc impacts up to 75,000 people in the United States. Interstitial lung disease, which may occur in approximately 80% of SSc patients, causes inflammation and scarring of the lungs and can be life-threatening. The FDA approval is based on data from the focuSSced trial, a Phase III randomized, double-blind, placebo-controlled clinical trial of 212 adults with systemic sclerosis. Supportive information was also used from the faSScinate trial, a Phase II/III, randomized, double-blind, placebo-controlled study in patients with SSc. The focuSSced trial did not meet its primary endpoint of change from baseline to week 48 in the modified Rodnan Skin Score, which is a standard outcome measure for skin fibrosis in SSc. There also was not a statistically significant effect on the primary endpoint of mRSS in the faSScinate trial."

ShowHide Related Items >><<
RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

03/03/21 Goldman Sachs
Adaptive Biotechnologies downgraded to Neutral from Buy at Goldman Sachs
02/25/21 Berenberg
Roche price target lowered to CHF 320 from CHF 325 at Berenberg
02/24/21 Morgan Stanley
Roche price target lowered to CHF 345 from CHF 365 at Morgan Stanley
02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

Hot Stocks
Avery Dennison VP Deena Baker sold almost $450K in company shares » 17:38
03/04/21
03/04
17:38
03/04/21
17:38
AVY

Avery Dennison

$172.04 /

-6.45 (-3.61%)

Avery Dennison VP Deena…

Avery Dennison VP Deena Baker disclosed in a filing that she had sold 2,500 shares of company stock at $179.46 per share on March 3, for a total transaction amount of $448,653.

ShowHide Related Items >><<
AVY Avery Dennison
$172.04 /

-6.45 (-3.61%)

AVY Avery Dennison
$172.04 /

-6.45 (-3.61%)

02/10/21 Argus
Avery Dennison upgraded to Buy from Hold at Argus
02/05/21 Loop Capital
Avery Dennison price target raised to $187 from $164 at Loop Capital
01/07/21 Citi
Sealed Air upgraded to Buy from Neutral at Citi
01/07/21 Citi
Avery Dennison upgraded to Buy from Neutral at Citi
AVY Avery Dennison
$172.04 /

-6.45 (-3.61%)

AVY Avery Dennison
$172.04 /

-6.45 (-3.61%)

AVY Avery Dennison
$172.04 /

-6.45 (-3.61%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.